MIRABEX 25 (Mirabegron 25 mg)

MIRABEX 25 contains Mirabegron 25 mg, a beta-3 adrenergic receptor agonist used for the treatment of Overactive Bladder (OAB). It works by relaxing the bladder muscle during the storage phase of the urinary cycle, increasing bladder capacity and reducing the sudden urge to urinate. This helps improve bladder control and minimizes episodes of urinary urgency, frequency, and urge urinary incontinence.

MIRABEX 25 is commonly prescribed for adults experiencing symptoms of overactive bladder that interfere with daily activities and quality of life. Regular use under the guidance of a healthcare professional may help reduce frequent daytime and nighttime urination, improve bladder function, and provide long-lasting symptom relief. The medicine is generally well tolerated and offers an effective treatment option for patients who require better bladder control. Manufactured under stringent quality standards, MIRABEX 25 provides reliable support for the long-term management of overactive bladder.

Key Benefits

• Helps manage symptoms of overactive bladder (OAB).
• Reduces urinary urgency, frequency, and urge incontinence.
• Increases bladder storage capacity.
• Improves bladder control and daily comfort.
• Suitable for long-term management under medical supervision.

Indications

• Overactive Bladder (OAB)
• Urinary Urgency
• Increased Urinary Frequency
• Urge Urinary Incontinence

Frequently Asked Questions

1. What is MIRABEX 25 used for?
MIRABEX 25 is used to treat overactive bladder by reducing urinary urgency, frequent urination, and urge urinary incontinence. It helps improve bladder control and quality of life.

2. How does Mirabegron work?
Mirabegron relaxes the bladder muscle during the filling phase, allowing the bladder to store more urine and reducing the frequent urge to urinate.

3. Can MIRABEX 25 be taken daily?
Yes. MIRABEX 25 is usually prescribed as a once-daily medication and should be taken regularly as directed by a healthcare professional for the best therapeutic results.